Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Adult Essential Thrombocythemia

Clinical trial NCT05395507 · UNKNOWN

Trial details

NCT number: NCT05395507
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Essential Thrombocytopenia

Start date: 2022-06-01
Primary completion: 2025-03-31
Enrollment: 194

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.